NCT07332000 2026-03-20A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecCandel Therapeutics, Inc.Phase 2 Recruiting45 enrolled
NCT00634231 2023-08-25A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain TumorsCandel Therapeutics, Inc.Phase 1 Completed8 enrolled